Meloxicam Sandoz

Meloxicam, the active ingredient in Meloxicam Sandoz, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral dosage form for oral use. It belongs to the NSAID class and works by inhibiting cyclooxygenase enzymes, reducing prostaglandin production, and is used to relieve pain and inflammation associated with osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and acute pain in adults.

GNH USA supplies Meloxicam Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Meloxicam is an NSAID that reduces inflammation by inhibiting cyclooxygenase enzymes, and it is indicated for several musculoskeletal conditions.

- Osteoarthritis: reduces joint pain and improves functional ability. - Rheumatoid arthritis: decreases synovial inflammation and slows disease progression. - Ankylosing spondylitis: alleviates spinal pain and stiffness. - Acute pain: provides short‑term relief of moderate pain.

Common Side Effects: - Gastrointestinal upset: nausea, dyspepsia, or abdominal discomfort. - Headache: mild to moderate intensity. - Dizziness or vertigo. - Peripheral edema: swelling of the lower limbs. - Elevated blood pressure. - Skin rash or pruritus.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding. - Cardiovascular events such as myocardial infarction or stroke. - Hepatic enzyme elevation or liver injury. - Severe skin reactions (e.g., Stevens‑Johnson syndrome). - Acute renal impairment or failure. - Anaphylaxis or severe hypersensitivity reactions.

Before initiating therapy, clinicians should evaluate patient‑specific risk factors and monitor for adverse events. - Assess renal function: obtain baseline creatinine and eGFR. - Monitor hepatic status: check liver enzymes in patients with liver disease. - Evaluate cardiovascular risk: use caution in patients with a history of heart disease. - Review concomitant medications: avoid combining with other NSAIDs or anticoagulants when possible. - Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Meloxicam may interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of serious bleeding. - Other NSAIDs or COX‑2 inhibitors: heightened gastrointestinal toxicity. - Lithium: meloxicam can raise lithium serum concentrations. - ACE inhibitors/ARBs in renal‑impaired patients: risk of acute kidney injury.

Moderate Interactions (Monitor Closely): - Diuretics: may reduce renal perfusion and exacerbate renal dysfunction. - Methotrexate: potential for increased methotrexate toxicity. - Cyclosporine: additive nephrotoxic effects. - SSRIs or SNRIs: modestly increased bleeding risk.